Archive: 02/06/2015

Diagnosed one of the few cases in the world of Hodgkin's lymphoma located outside of the nodules

Dr. Jerónimo Forteza, Professor of Pathology and Director of the Valencian Institute of Pathology, Catholic University of Valencia San Vicente Mártir, recently published an article in the Spanish Journal of Pathology on ...

Jun 2, 2015

0

6

Researchers describe regulatory protein controlling the patterning of the lymphatic system

The lymphatic vasculature is vital for the function of the immune system, but its development is poorly understood in comparison to that of the blood vasculature from which it arises. The vessels that make up the lymphatic ...

Jun 2, 2015

0

31

Many health impacts of aging are due to inactivity—not getting old

This past winter I taught a course titled "Physical Activity and Aging." It was a fun course, and really drove home an issue that I've known for a while, but hadn't previously given a lot of thought: the impact of aging ...

Jun 2, 2015

1

888

FDA addresses concerns on approval of drugs to treat chronic hepatitis C

Treatment options for chronic hepatitis C, a serious and life-threatening infection, have improved substantially and several new regimens with shorter durations and improved efficacy and safety profiles are now available.

Jun 2, 2015

0

11

Noncoding RNA CCDC26 regulates KIT expression

A long, noncoding RNA (lncRNA), which might have impact on tyrosine kinase-targeted leukemia therapy, was found to be expressed in a leukemia cell line. The function of the lncRNA CCDC26 is not fully understood; however, ...

Jun 2, 2015

Remote ischemic preconditioning cuts kidney injury risk

(HealthDay)—Remote ischemic preconditioning can reduce the rate of acute kidney injury among high-risk patients undergoing cardiac surgery, according to a study published online May 29 in the Journal of the American Medical ...

Jun 2, 2015

0

5

Researchers report innovative grass pollen allergy vaccine

Biomay, a global leader in allergy immunotherapy, announced today that the results of a landmark phase IIb study with its 3rd generation grass pollen allergy vaccine BM32 will be reported at the EAACI Congress 2015 in Barcelona, ...

Jun 2, 2015